Skip to main content
Erschienen in: Journal of Nuclear Cardiology 2/2023

01.08.2022 | Original Article

125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging visualized augmented sigma-1 receptor expression according to the severity of myocardial ischemia

verfasst von: Hiroshi Wakabayashi, MD, PhD, Hiroshi Mori, MD, PhD, Tomo Hiromasa, MD, PhD, Norihito Akatani, MD, Anri Inaki, MD, PhD, Takashi Kozaka, PhD, Yoji Kitamura, PhD, Kazuma Ogawa, PhD, Seigo Kinuya, MD, PhD, Junichi Taki, MD, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to explore how the severity of myocardial ischemia affects myocardial sigma-1 receptor (Sig-1R) expression using 125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging.

Methods and results

The left coronary artery was occluded for 30, 20, and 10 minute, to vary the severity of myocardial ischemia, followed by reperfusion. Dual-tracer autoradiography of the left ventricular short-axis slices was performed 3 and 7 days after reperfusion. 125I-OI5V was injected 30 minute before sacrifice and the area at risk (AAR) was evaluated by 99mTc-MIBI. Intense 125I-OI5V uptake was observed in the AAR and was significantly increased with increasing ischemia duration. To evaluate salvaged and nonsalvaged areas (preserved and decreased perfusion areas), triple-tracer autoradiography was performed 3 days after reperfusion. After dual-tracer autoradiography, 201Tl was injected 20 minute post 125I-OI5V injection. On triple-tracer autoradiography, the AAR/normally perfused area 125I-OI5V uptake ratio was positively correlated with the nonsalvaged area/whole left ventricular (LV) area ratio (P < .05). The AAR/normally perfused area 125I-OI5V uptake ratio was negatively correlated with the 201Tl uptake ratio of the AAR to normally perfused areas (P < .05). The comparison of the immunostaining distribution of 125I-OI5V and the macrophage marker CD68 revealed that 125I-OI5V was present mainly in, and immediately adjacent to the macrophage infiltration area.

Conclusions

Significant 125I-OI5V uptake in the AAR depends on the duration of ischemia and reduced 201Tl uptake; furthermore, 125I-OI5V was found in and around the macrophage infiltrate area. These results indicate that iodine-labeled OI5V is a promising tool for visualizing Sig-1R expression according to the ischemic burden.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Shigeno T, Kozaka T, Kitamura Y, Ogawa K, Taki J, Kinuya S. In vitro and in vivo evaluation of [(125/123)I]-2-[4-(2-iodophenyl)piperidino]cyclopentanol([(125/123)I]-OI5V) as a potential sigma-1 receptor ligand for SPECT. Ann Nucl Med 2021;35:167‐75.CrossRefPubMed Shigeno T, Kozaka T, Kitamura Y, Ogawa K, Taki J, Kinuya S. In vitro and in vivo evaluation of [(125/123)I]-2-[4-(2-iodophenyl)piperidino]cyclopentanol([(125/123)I]-OI5V) as a potential sigma-1 receptor ligand for SPECT. Ann Nucl Med 2021;35:167‐75.CrossRefPubMed
2.
3.
4.
Zurück zum Zitat Penke B, Fulop L, Szucs M, Frecska E. The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases. Curr Neuropharmacol 2018;16:97‐116.PubMedPubMedCentral Penke B, Fulop L, Szucs M, Frecska E. The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases. Curr Neuropharmacol 2018;16:97‐116.PubMedPubMedCentral
5.
Zurück zum Zitat Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995;55:408‐13.PubMed Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995;55:408‐13.PubMed
6.
Zurück zum Zitat Tagashira H, Bhuiyan S, Shioda N, Hasegawa H, Kanai H, Fukunaga K. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol 2010;299:H1535‐45.CrossRefPubMed Tagashira H, Bhuiyan S, Shioda N, Hasegawa H, Kanai H, Fukunaga K. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol 2010;299:H1535‐45.CrossRefPubMed
7.
Zurück zum Zitat Wakabayashi H, Taki J, Mori H, Hiromasa T, Akatani N, Inaki A, et al. Visualization of dynamic expression of myocardial sigma-1 receptor after myocardial ischemia and reperfusion using radioiodine-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) imaging. Circ J 2021;85:2102‐8.CrossRefPubMed Wakabayashi H, Taki J, Mori H, Hiromasa T, Akatani N, Inaki A, et al. Visualization of dynamic expression of myocardial sigma-1 receptor after myocardial ischemia and reperfusion using radioiodine-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) imaging. Circ J 2021;85:2102‐8.CrossRefPubMed
8.
Zurück zum Zitat Lewis R, Li J, McCormick PJ, Christoper LHH, Jeevaratnam K. Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review. Int J Cardiol Heart Vasc 2020;26:100449.PubMed Lewis R, Li J, McCormick PJ, Christoper LHH, Jeevaratnam K. Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review. Int J Cardiol Heart Vasc 2020;26:100449.PubMed
9.
Zurück zum Zitat Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 1994;269:1300‐9.PubMed Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 1994;269:1300‐9.PubMed
10.
Zurück zum Zitat Novakova M, Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol 1995;286:19‐30.CrossRefPubMed Novakova M, Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol 1995;286:19‐30.CrossRefPubMed
11.
Zurück zum Zitat Taki J, Higuchi T, Kawashima A, Tait JF, Muramori A, Matsunari I, et al. (99m)Tc-Annexin-V uptake in a rat model of variable ischemic severity and reperfusion time. Circ J 2007;71:1141‐6.CrossRefPubMed Taki J, Higuchi T, Kawashima A, Tait JF, Muramori A, Matsunari I, et al. (99m)Tc-Annexin-V uptake in a rat model of variable ischemic severity and reperfusion time. Circ J 2007;71:1141‐6.CrossRefPubMed
12.
Zurück zum Zitat Wakabayashi H, Taki J, Inaki A, Shiba K, Matsunari I, Kinuya S. Correlation between apoptosis and left ventricular remodeling in subacute phase of myocardial ischemia and reperfusion. EJNMMI Res 2015;5:72.CrossRefPubMedPubMedCentral Wakabayashi H, Taki J, Inaki A, Shiba K, Matsunari I, Kinuya S. Correlation between apoptosis and left ventricular remodeling in subacute phase of myocardial ischemia and reperfusion. EJNMMI Res 2015;5:72.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Taki J, Wakabayashi H, Inaki A, Imanaka-Yoshida K, Hiroe M, Ogawa K, et al. 14C-Methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion. J Nucl Med 2013;54:431‐6.CrossRefPubMed Taki J, Wakabayashi H, Inaki A, Imanaka-Yoshida K, Hiroe M, Ogawa K, et al. 14C-Methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion. J Nucl Med 2013;54:431‐6.CrossRefPubMed
14.
Zurück zum Zitat Tarone G, Brancaccio M. Keep your heart in shape: Molecular chaperone networks for treating heart disease. Cardiovasc Res 2014;102:346‐61.CrossRefPubMed Tarone G, Brancaccio M. Keep your heart in shape: Molecular chaperone networks for treating heart disease. Cardiovasc Res 2014;102:346‐61.CrossRefPubMed
15.
Zurück zum Zitat Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, et al. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using Tc-99m-labeled annexin V. J Nucl Med 2004;45:1536‐41.PubMed Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, et al. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using Tc-99m-labeled annexin V. J Nucl Med 2004;45:1536‐41.PubMed
16.
Zurück zum Zitat Taki J, Inaki A, Wakabayashi H, Imanaka-Yoshida K, Ogawa K, Hiroe M, et al. Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: Assessment by 125I-anti-tenascin-C antibody imaging. J Nucl Med 2010;51:1116‐22.CrossRefPubMed Taki J, Inaki A, Wakabayashi H, Imanaka-Yoshida K, Ogawa K, Hiroe M, et al. Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: Assessment by 125I-anti-tenascin-C antibody imaging. J Nucl Med 2010;51:1116‐22.CrossRefPubMed
17.
Zurück zum Zitat Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF. Dynamics of cardiac wound healing following myocardial infarction: Observations in genetically altered mice. Acta Physiol Scand 2001;173:75‐82.CrossRefPubMed Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF. Dynamics of cardiac wound healing following myocardial infarction: Observations in genetically altered mice. Acta Physiol Scand 2001;173:75‐82.CrossRefPubMed
19.
Zurück zum Zitat Ruiz-Cantero MC, Gonzalez-Cano R, Tejada MA, Santos-Caballero M, Perazzoli G, Nieto FR, et al. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain. Pharmacol Res 2021;163:105339.CrossRefPubMed Ruiz-Cantero MC, Gonzalez-Cano R, Tejada MA, Santos-Caballero M, Perazzoli G, Nieto FR, et al. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain. Pharmacol Res 2021;163:105339.CrossRefPubMed
20.
Zurück zum Zitat Bravo-Caparros I, Ruiz-Cantero MC, Perazzoli G, Cronin SJF, Vela JM, Hamed MF, et al. Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury. FASEB J 2020;34:5951‐66.CrossRefPubMed Bravo-Caparros I, Ruiz-Cantero MC, Perazzoli G, Cronin SJF, Vela JM, Hamed MF, et al. Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury. FASEB J 2020;34:5951‐66.CrossRefPubMed
21.
Zurück zum Zitat Scholz J, Woolf CJ. The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 2007;10:1361‐8.CrossRefPubMed Scholz J, Woolf CJ. The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 2007;10:1361‐8.CrossRefPubMed
Metadaten
Titel
125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging visualized augmented sigma-1 receptor expression according to the severity of myocardial ischemia
verfasst von
Hiroshi Wakabayashi, MD, PhD
Hiroshi Mori, MD, PhD
Tomo Hiromasa, MD, PhD
Norihito Akatani, MD
Anri Inaki, MD, PhD
Takashi Kozaka, PhD
Yoji Kitamura, PhD
Kazuma Ogawa, PhD
Seigo Kinuya, MD, PhD
Junichi Taki, MD, PhD
Publikationsdatum
01.08.2022
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 2/2023
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-022-03064-8

Weitere Artikel der Ausgabe 2/2023

Journal of Nuclear Cardiology 2/2023 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.